COTA provides oncology research and development, regulatory, commercial, and HEOR teams with detailed real-world patient data to discover new treatment protocols and transform cancer care.
Real, longitudinal patient data across dozens of patient subgroups and oncology disease areas help pharmaceutical and biotech companies optimize their research, development, and commercialization strategies.
COTA data includes over 2M+ patients across a variety of cancer diagnoses, treatment settings, and demographics and is regularly maintained and updated to ensure quality, accuracy, relevance, and linkability.
Get access to a massive database of longitudinal real-world outcomes datasets curated to specific cancer types, subpopulations, or broad population research.
Get expert clinical insights, study design support, and statistical analysis.
Explore our collection of clinical research, recent press, podcasts, and more.
Cancer is a disease that respects no borders: it affects everyone around the world, no matter where they live. The universal nature of cancer makes it even more important for international partners to collaborate…
3 key takeaways from ASCO 2025: Staying nimble in a changing environment The annual meeting of the American Society of Clinical Oncology (ASCO) is a chance for oncology professionals, patient advocates, data experts, and…
Each year, ISPOR brings together members of the health economics and outcomes research (HEOR) community for a celebration of the latest research and innovative methodology to push forward data-driven, patient-centered decision-making across the life…
Partner with COTA for the highest-quality curated cancer patient datasets.
